The Use of Cell Therapies for Autoimmune Diseases: MSCs from Biology to Clinical Application

ISCT Institute of Training and Development - The Global Leader in CGT Workforce Development


This 1.5-day training course is designed to teach you the applications of MSCs for treating auto-immune diseases, including rheumatic diseases (systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis), immune-neurological diseases (multiple-sclerosis, autism) and gastrointestinal diseases (Crohn's disease) as well as European ATMP framework.

You will also gain an understanding of the regulatory requirements for using MSCs in clinical applications, specifically on the study design, conduct, analysis and recommendations for developing clinical trials.


course content:
  • MSC biology, regulatory requirements, and statistical approaches for clinical applications.
  • ATMP framework in Europe.
  • Applications and mechanisms of MSCs for CGT auto-immune diseases.
  • Manuscript - Recommendations for clinical trials.

Learning outcome:
  • Have a basic understanding of MSC biology.
  • Know the statistical considerations for clinical trial design when using MSC to treat auto-immune diseases.
  • Understand the process behind the production, regulation, and quality of MSC cell products.
  • Have an understanding of the clinical applications of MSCs for auto-immune diseases.
  • Understand the key principles for developing clinical trials.

Price (USD):
ISCT Member

Non Member

(registration fee includes e-membership for 2024)

Students/Residents/Postdocs/Fellows $195 $240
Others $295 $470

Cancellation Policy: Registration cancellation must be made by email to at least twenty (20) business days before the course start date. A 10% administrative fee is applied to all cancellations.  Registration fee is non-refundable if it is cancelled within twenty (20) business days of the course start date.

    Upcoming Course Dates:
    • Thursday, January 25, 2024 - Friday, January 26, 2024
      Deadline to register: Oct 31, 2023

      Course will be conducted in English, in-person at Hôpital Saint-Louis AP-HP, Paris, France 

      Designed for:
      • Clinicians and clinicians-in-training, researchers, and pharmacists looking to increase knowledge on the use of MSCs from lab to clinical application for CGT in auto-immune diseases.
      • 1.5-days, in-person interactive training course
      • Hôpital Saint-Louis AP-HP, Paris, France 

      Eligibility requirements:
      • None
      upon completion, you will receive:

      • Certificates of course completion from ISCT.
      • EBAH-CME certificate upon completion of the course.

      This course has been accepted by the European Board for Accreditation in Hematology (EBAH). This course consists of 12 CME credits.

      Planning Committee:

       Headshot of Dominique Farge

      Dominique Farge, MD, PhD

      Regional Vice-President Elect

      St Louis Hospital Assistance Publique-Hôpitaux De Paris
      Paris-Cité University, Paris, France

      Fermín Sánchez‐Guijo, MD, PhD 

      Regional Vice-President

      IBSAL-Hospital Universitario De Salamanca
      Salamanca, Spain

      Massimiliano Gnecchi, MD, PhD, FESC

      University of Pavia & IRCCS Policlinico
      San Matteo Hospital, Pavia, Italy



      Host institution:
      Site of the Saint-Louis Hospital, located in the 10th arrondissement of Paris


      Unrestricted Educational Grant Provided by: